2016 Q2 Form 10-Q Financial Statement

#000156459016023008 Filed on August 05, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $386.5M $351.7M
YoY Change 9.9% 0.12%
Cost Of Revenue $219.8M $208.1M
YoY Change 5.64% -1.52%
Gross Profit $166.7M $143.6M
YoY Change 16.06% 2.6%
Gross Profit Margin 43.12% 40.83%
Selling, General & Admin $94.80M $86.75M
YoY Change 9.28% 0.1%
% of Gross Profit 56.88% 60.4%
Research & Development $47.89M $44.37M
YoY Change 7.94% -16.31%
% of Gross Profit 28.73% 30.89%
Depreciation & Amortization $42.10M $41.80M
YoY Change 0.72% -4.13%
% of Gross Profit 25.26% 29.1%
Operating Expenses $142.7M $131.1M
YoY Change 8.83% -6.13%
Operating Profit $18.57M $5.591M
YoY Change 232.21% -161.49%
Interest Expense $16.42M -$7.500M
YoY Change -318.95% -203.73%
% of Operating Profit 88.41% -134.14%
Other Income/Expense, Net $106.0K -$28.00K
YoY Change -478.57% -112.17%
Pretax Income -$2.639M -$1.744M
YoY Change 51.32% -89.16%
Income Tax -$503.0K $1.472M
% Of Pretax Income
Net Earnings -$10.20M -$3.225M
YoY Change 216.34% -81.85%
Net Earnings / Revenue -2.64% -0.92%
Basic Earnings Per Share -$0.05 -$0.01
Diluted Earnings Per Share -$0.05 -$0.01
COMMON SHARES
Basic Shares Outstanding 186.8M 181.6M
Diluted Shares Outstanding 186.8M 181.6M

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.70M $76.50M
YoY Change 18.56% 94.66%
Cash & Equivalents $90.06M $76.50M
Short-Term Investments
Other Short-Term Assets $107.8M $140.1M
YoY Change -23.05% -15.81%
Inventory
Prepaid Expenses
Receivables $395.6M $323.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $594.1M $540.1M
YoY Change 10.0% -0.44%
LONG-TERM ASSETS
Property, Plant & Equipment $143.7M $135.5M
YoY Change 6.07% -16.94%
Goodwill $1.847B
YoY Change
Intangibles $794.7M $52.00M
YoY Change 1428.27% -89.13%
Long-Term Investments $2.436M $0.00
YoY Change -100.0%
Other Assets $122.0M $347.4M
YoY Change -64.88% 92.93%
Total Long-Term Assets $3.116B $2.164B
YoY Change 44.01% 5.55%
TOTAL ASSETS
Total Short-Term Assets $594.1M $540.1M
Total Long-Term Assets $3.116B $2.164B
Total Assets $3.710B $2.704B
YoY Change 37.21% 4.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $84.46M $72.00M
YoY Change 17.3% -6.93%
Accrued Expenses $65.70M $110.9M
YoY Change -40.76% 32.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $12.08M $33.70M
YoY Change -64.16% 53.88%
Total Short-Term Liabilities $607.3M $521.0M
YoY Change 16.56% 0.62%
LONG-TERM LIABILITIES
Long-Term Debt $1.166B $628.9M
YoY Change 85.42% 17.14%
Other Long-Term Liabilities $74.00M $106.0M
YoY Change -30.19% -13.43%
Total Long-Term Liabilities $1.240B $734.9M
YoY Change 68.74% 11.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $607.3M $521.0M
Total Long-Term Liabilities $1.240B $734.9M
Total Liabilities $2.370B $1.321B
YoY Change 79.39% 2.15%
SHAREHOLDERS EQUITY
Retained Earnings -$190.2M
YoY Change
Common Stock $1.795B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $241.8M
YoY Change
Treasury Stock Shares $81.29M
Shareholders Equity $1.340B $1.383B
YoY Change
Total Liabilities & Shareholders Equity $3.710B $2.704B
YoY Change 37.21% 4.3%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$10.20M -$3.225M
YoY Change 216.34% -81.85%
Depreciation, Depletion And Amortization $42.10M $41.80M
YoY Change 0.72% -4.13%
Cash From Operating Activities $56.20M $30.30M
YoY Change 85.48% 78.24%
INVESTING ACTIVITIES
Capital Expenditures -$30.80M -$15.90M
YoY Change 93.71% 11.97%
Acquisitions
YoY Change
Other Investing Activities -$925.7M -$218.7M
YoY Change 323.27% 2600.0%
Cash From Investing Activities -$956.5M -$234.5M
YoY Change 307.89% 951.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $14.50M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 891.2M 192.2M
YoY Change 363.68% 6764.29%
NET CHANGE
Cash From Operating Activities 56.20M 30.30M
Cash From Investing Activities -956.5M -234.5M
Cash From Financing Activities 891.2M 192.2M
Net Change In Cash -9.100M -12.00M
YoY Change -24.17% 380.0%
FREE CASH FLOW
Cash From Operating Activities $56.20M $30.30M
Capital Expenditures -$30.80M -$15.90M
Free Cash Flow $87.00M $46.20M
YoY Change 88.31% 48.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
16421000
CY2016Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
97646000
CY2016Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2488000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
121993000
CY2016Q2 us-gaap Assets
Assets
3710097000
CY2016Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
136650000
CY2016Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1351207000
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
267844000
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
186556000
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
81288000
CY2016Q2 mdrx Software Delivery Support And Maintenance Costs
SoftwareDeliverySupportAndMaintenanceCosts
79154000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47891000
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
107810000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
594094000
CY2016Q2 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
187500000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
143731000
CY2016Q2 us-gaap Goodwill
Goodwill
1846944000
CY2016Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
715701000
CY2016Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
9986000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
84455000
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1791838000
CY2016Q2 mdrx Non Recourse Long Term Debt Noncurrent
NonRecourseLongTermDebtNoncurrent
523381000
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65696000
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
241827000
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
52440000
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
373543000
CY2016Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
12077000
CY2016Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
367302000
CY2016Q2 mdrx Non Recourse Long Term Debt Current
NonRecourseLongTermDebtCurrent
11602000
CY2016Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
7509000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-190235000
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
2678000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-22427000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
1340027000
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5417000
CY2016Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
18574000
CY2016Q2 us-gaap Minority Interest
MinorityInterest
11180000
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3710097000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
349000000
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34649000
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 mdrx Software Delivery Support And Maintenance Revenue
SoftwareDeliverySupportAndMaintenanceRevenue
249871000
CY2016Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4898000
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-87000
CY2016Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
8153000
CY2016Q2 us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
22000000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-87000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21245000
CY2016Q2 us-gaap Cost Method Investments
CostMethodInvestments
26041000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
106000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2639000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-503000
CY2016Q2 us-gaap Profit Loss
ProfitLoss
-2136000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-10202000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-943000
CY2016Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-18115000
CY2016Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
-227000
CY2016Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-19285000
CY2016Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-89000
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19196000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-21332000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
962000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7363000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1638000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
51362000
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
599135000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
52075000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
76576000
us-gaap Share Based Compensation
ShareBasedCompensation
20057000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
962000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1560000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8464000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12407000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2923000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15751000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8709000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-11404000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
37623000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1106000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
132099000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16632000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
37106000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
20685000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
905540000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
37000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-979926000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
333605000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
821269000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
340000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-26218000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53173000
mdrx Exchange Of Common Stock For Redeemable Convertible Preferred Stock
ExchangeOfCommonStockForRedeemableConvertiblePreferredStock
25543000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and the accompanying notes. Actual results could differ materially from these estimates.</p></div>
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Accounting Pronouncements Not yet Adopted</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. 2014-09, <font style="font-style:italic;">Revenue from Contracts with Customers: Topic </font>606 (&#8220;ASU 2014-09&#8221;), to supersede nearly all existing revenue recognition guidance under GAAP. The core principle of ASU 2014-09 is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASU 2014-09 defines a five-step process to achieve this principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The new standard permits the use of either the retrospective or cumulative effect transition methods. As issued, ASU 2014-09 is effective for us for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. On August 12, 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU 2014-09 by one year to annual reporting periods beginning after December 15, 2017, while also permitting companies to voluntarily adopt the new revenue standard as of the original effective date. In addition, during the first half of 2016 the FASB issued ASU 2016-08, ASU 2016-10, 2016-11 and 2016-12, all of which clarify certain implementation guidance within ASU 2014-09. We have initiated an assessment of our systems, data and processes related to the implementation of this accounting standard. This assessment is expected to be completed during fiscal 2016. Additionally, we are currently evaluating the potential impact that the implementation of this standard will have on our consolidated financial statements, as well as the selection of the method of adoption. We currently do not expect to implement this standard prior to its mandatory effective date. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> In March 2016, the FASB issued Accounting Standards Update No. 2016-07, <font style="font-style:italic;">Investments &#8211; Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting</font> (&#8220;ASU 2016-07&#8221;). The guidance in ASU 2016-07 eliminates the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations, and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The amendments require that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor&#8217;s previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. The amendments in this Update require that an entity that has an available-for-sale equity security that becomes qualified for the equity method of accounting recognize through earnings the unrealized holding gain or loss in accumulated other comprehensive income at the date the investment becomes qualified for use of the equity method. ASU 2016-07 is effective for interim and annual periods beginning after December 15, 2016, and should be applied prospectively. Earlier application is permitted. We are currently evaluating the impact of this new accounting guidance.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, the FASB issued Accounting Standards Update No. 2016-09, <font style="font-style:italic;">Compensation &#8211; Stock Compensation (Topic 718): Improvements to Share-Based Payment Accounting</font> (&#8220;ASU 2016-09&#8221;). The guidance in ASU 2016-09 affects several aspects of the accounting for employee share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. Excess tax benefits and deficiencies will now be recognized as income tax expense or benefit in the income statement. Entities will also be able to make an accounting policy election to account for forfeitures as they occur rather than estimating the number of awards expected to vest. ASU 2016-09 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted. We are currently in the process of evaluating this new guidance, which we expect to have an impact on our consolidated financial statements and results of operations.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the FASB issued Accounting Standards Update No. 2016-13, <font style="font-style:italic;">Financial Instruments &#8211; Credit Losses (Topic 326):&nbsp;&nbsp;Measurement of Credit Losses on Financial Instruments</font> (&#8220;ASU 2016-13&#8221;). The guidance in ASU 2016-13 replaces the incurred loss impairment methodology under current GAAP. The new impairment model requires immediate recognition of estimated credit losses expected to occur for most financial assets and certain other instruments. For available-for-sale debt securities with unrealized losses, the losses will be recognized as allowances rather than reductions in the amortized cost of the securities. ASU 2016-13 is effective for annual periods beginning after December 15, 2019, and interim periods within those annual periods. Early adoption for fiscal years beginning after December 15, 2018 is permitted. We are currently in the process of evaluating this new guidance, which we expect to have an impact on our consolidated financial statements and results of operations. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not believe that any other recently issued, but not yet effective accounting standards, if adopted, would have a material impact on our consolidated financial statements.</p></div>
mdrx Contribution And Investment Agreement Date Of Agreement
ContributionAndInvestmentAgreementDateOfAgreement
2016-03-20
mdrx Netsmart Transaction Completion Date
NetsmartTransactionCompletionDate
2016-04-19
mdrx Description Of Liquidation Preference
DescriptionOfLiquidationPreference
The liquidation preference is equal to the greater of (i) a return of the original issue price plus a preferred return (accruing on a daily basis at the rate of 11% per annum and compounding annually on the last day of each calendar year) or (ii) the as-converted value of Class A Common Units in Nathan.
mdrx Preferred Stock Liquidation Preferred Return Percentage
PreferredStockLiquidationPreferredReturnPercentage
0.11
mdrx Preferred Stock Liquidation Percentage Of Redemption Preference
PreferredStockLiquidationPercentageOfRedemptionPreference
0.11
CY2016Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.491
CY2016Q2 mdrx Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles And Capitalized Software Development Costs Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangiblesAndCapitalizedSoftwareDevelopmentCostsNet
397500000
CY2016Q2 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
187396000
mdrx Number Of Equity Method Investments
NumberOfEquityMethodInvestments
3
CY2016Q2 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
1658000
CY2016Q2 us-gaap Equity Method Investments
EquityMethodInvestments
2436000
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
52482000
CY2016Q1 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
45920000
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
191563000
CY2016Q1 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
379957000
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
195713000
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000
CY2016Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1200000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4100000
CY2016Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
14500000
CY2016Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
98000000
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
186792000
CY2016Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
28557000
CY2015Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
3019000
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
51893000
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
5729000
CY2015Q4 us-gaap Equity Method Investments
EquityMethodInvestments
205553000
mdrx Number Of Cost Method Investments
NumberOfCostMethodInvestments
5
CY2016Q2 us-gaap Cost Method Investments Original Cost
CostMethodInvestmentsOriginalCost
29991000
CY2015Q4 us-gaap Cost Method Investments
CostMethodInvestments
17876000
mdrx Number Of Equity And Cost Method Investments
NumberOfEquityAndCostMethodInvestments
8
CY2016Q2 mdrx Equity And Cost Method Investments Original Investment
EquityAndCostMethodInvestmentsOriginalInvestment
31649000
CY2016Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
28477000
CY2015Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
223429000
CY2016Q1 mdrx Payments To Acquire Cost And Equity Method Investments
PaymentsToAcquireCostAndEquityMethodInvestments
500000
mdrx Payment To Acquire Non Marketable Equity Securities
PaymentToAcquireNonMarketableEquitySecurities
10200000
CY2016Q1 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
69491000
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
42239000
CY2016Q1 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
571076000
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
397519000
CY2016Q1 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
214690000
CY2016Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-35385000
CY2015Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
234000
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-59925000
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
18000
CY2016Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2015Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10660000
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10018000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21061000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19536000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
193000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3161000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.08
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1300000
CY2015 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1400000
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
564000
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
422000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
186792000
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25210000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
625273000
us-gaap Goodwill Transfers
GoodwillTransfers
0
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-930000
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
181558000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
187676000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
181072000
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181558000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
187676000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181072000
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23759000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25227000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23351000
CY2016Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1372709000
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
736008000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
636701000
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1003247000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
707601000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
295646000
CY2016Q2 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
79000000
CY2015Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
52000000
CY2016Q2 mdrx Indefinite Lived Intangible Assets Including Goodwill
IndefiniteLivedIntangibleAssetsIncludingGoodwill
1925944000
CY2015Q4 mdrx Indefinite Lived Intangible Assets Including Goodwill
IndefiniteLivedIntangibleAssetsIncludingGoodwill
1274601000
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
400000
CY2016Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1267696000
CY2016Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
87937000
CY2016Q2 us-gaap Long Term Debt
LongTermDebt
1179759000
CY2015Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
692058000
CY2015Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
67475000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
624583000
CY2016Q2 mdrx Debt Instrument Face Amount Current
DebtInstrumentFaceAmountCurrent
12570000
CY2016Q2 mdrx Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
493000
CY2015Q4 mdrx Debt Instrument Face Amount Current
DebtInstrumentFaceAmountCurrent
12657000
CY2015Q4 mdrx Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
479000
CY2016Q2 mdrx Debt Instrument Face Amount Noncurrent
DebtInstrumentFaceAmountNoncurrent
1239326000
CY2016Q2 mdrx Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
83246000
CY2016Q2 mdrx Long Term Debt And Non Recourse Long Term Debt Noncurrent
LongTermDebtAndNonRecourseLongTermDebtNoncurrent
1156080000
CY2015Q4 mdrx Debt Instrument Face Amount Noncurrent
DebtInstrumentFaceAmountNoncurrent
679401000
CY2015Q4 mdrx Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
66996000
CY2015Q4 mdrx Long Term Debt And Non Recourse Long Term Debt Noncurrent
LongTermDebtAndNonRecourseLongTermDebtNoncurrent
612405000
CY2016Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3595000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7133000
CY2016Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3448000
CY2016Q2 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
14221000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
31425000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
43925000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
56425000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
630800000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
490900000
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.191
CY2015Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.844
CY2015Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4008000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7869000
CY2015Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3418000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6879000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6813000
CY2015Q2 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
57000
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
57000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.038
CY2015Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
80632000
CY2015Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
81210000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.176
mdrx Cumulative Operating Income Loss Period
CumulativeOperatingIncomeLossPeriod
P3Y
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
0
CY2016Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13100000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11800000
CY2016Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
39136000
CY2016Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
39240000
CY2016Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
70000
CY2015Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-184000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
260000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-159000
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-18193000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-8000
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-251000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
140000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2016Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
89000
CY2015Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-90000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-943000
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
677000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-85000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-2000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-199000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-391000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5

Files In Submission

Name View Source Status
0001564590-16-023008-index-headers.html Edgar Link pending
0001564590-16-023008-index.html Edgar Link pending
0001564590-16-023008.txt Edgar Link pending
0001564590-16-023008-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mdrx-10q_20160630.htm Edgar Link pending
mdrx-20160630.xml Edgar Link completed
mdrx-20160630.xsd Edgar Link pending
mdrx-20160630_cal.xml Edgar Link unprocessable
mdrx-20160630_def.xml Edgar Link unprocessable
mdrx-20160630_lab.xml Edgar Link unprocessable
mdrx-20160630_pre.xml Edgar Link unprocessable
mdrx-ex103_317.htm Edgar Link pending
mdrx-ex104_318.htm Edgar Link pending
mdrx-ex311_7.htm Edgar Link pending
mdrx-ex312_8.htm Edgar Link pending
mdrx-ex322_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending